Susquehanna International Group’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.83M Buy
484,717
+176,526
+57% +$3.21M ﹤0.01% 806
2025
Q1
$6.11M Buy
308,191
+145,937
+90% +$2.9M ﹤0.01% 1016
2024
Q4
$2.78M Buy
162,254
+100,566
+163% +$1.72M ﹤0.01% 1593
2024
Q3
$1.23M Sell
61,688
-15,951
-21% -$319K ﹤0.01% 2420
2024
Q2
$868K Sell
77,639
-88,816
-53% -$993K ﹤0.01% 2748
2024
Q1
$1.1M Sell
166,455
-69,778
-30% -$461K ﹤0.01% 2513
2023
Q4
$1.07M Sell
236,233
-135,489
-36% -$612K ﹤0.01% 2777
2023
Q3
$1.33M Buy
371,722
+245,602
+195% +$879K ﹤0.01% 2238
2023
Q2
$465K Sell
126,120
-296,412
-70% -$1.09M ﹤0.01% 3720
2023
Q1
$1.4M Buy
422,532
+18,708
+5% +$61.9K ﹤0.01% 2400
2022
Q4
$1.57M Sell
403,824
-47,039
-10% -$183K ﹤0.01% 1830
2022
Q3
$1.1M Buy
450,863
+5,633
+1% +$13.7K ﹤0.01% 2421
2022
Q2
$882K Sell
445,230
-539,793
-55% -$1.07M ﹤0.01% 2593
2022
Q1
$1.8M Sell
985,023
-374,508
-28% -$686K ﹤0.01% 2123
2021
Q4
$1.92M Buy
1,359,531
+158,088
+13% +$223K ﹤0.01% 2030
2021
Q3
$1.36M Buy
1,201,443
+553,754
+85% +$626K ﹤0.01% 2390
2021
Q2
$1.04M Sell
647,689
-42,365
-6% -$67.8K ﹤0.01% 2929
2021
Q1
$1.21M Buy
690,054
+297,899
+76% +$524K ﹤0.01% 2735
2020
Q4
$765K Buy
392,155
+264,905
+208% +$517K ﹤0.01% 2901
2020
Q3
$304K Sell
127,250
-63,939
-33% -$153K ﹤0.01% 3506
2020
Q2
$560K Buy
191,189
+16,824
+10% +$49.3K ﹤0.01% 2806
2020
Q1
$502K Buy
174,365
+79,966
+85% +$230K ﹤0.01% 2869
2019
Q4
$378K Sell
94,399
-71,378
-43% -$286K ﹤0.01% 2934
2019
Q3
$738K Buy
165,777
+30,695
+23% +$137K ﹤0.01% 2406
2019
Q2
$523K Buy
135,082
+117,046
+649% +$453K ﹤0.01% 2870
2019
Q1
$68K Buy
+18,036
New +$68K ﹤0.01% 2740
2018
Q2
Sell
-94,476
Closed -$435K 3580
2018
Q1
$435K Buy
+94,476
New +$435K ﹤0.01% 2223
2015
Q2
Sell
-30,000
Closed -$294K 4430
2015
Q1
$294K Buy
+30,000
New +$294K ﹤0.01% 3481